characteristics.text: SAMN13852327
characteristics.characteristic: External Id
characteristics.text: DANA FARBER CANCER INSTITUTE INC
characteristics.characteristic: INSDC center name
characteristics.text: 2023-04-07T00:00:00Z
characteristics.characteristic: INSDC first public
characteristics.text: 2023-04-07T02:18:19.777Z
characteristics.characteristic: INSDC last update
characteristics.text: SRS5991877
characteristics.characteristic: INSDC secondary accession
characteristics.text: live
characteristics.characteristic: INSDC status
characteristics.text: Generic
characteristics.characteristic: NCBI submission model
characteristics.text: Generic.1.0
characteristics.characteristic: NCBI submission package
characteristics.text: SRS5991877
characteristics.characteristic: SRA accession
characteristics.text: CD8 T cells
characteristics.characteristic: cell type
characteristics.text: H3K27ac
characteristics.characteristic: chip antibody
characteristics.text: Day 5
characteristics.characteristic: day post-activation
characteristics.text: 10 μM RGFP966
characteristics.characteristic: drug treatment
characteristics.text: WT
characteristics.characteristic: hdac3 genotype
characteristics.text: Mus musculus
characteristics.ontologyTerms: http://purl.obolibrary.org/obo/NCBITaxon_10090
characteristics.characteristic: organism
characteristics.text: OT-I CD8 T cells
characteristics.characteristic: source_name
characteristics.text: OT-I transgenic
characteristics.characteristic: strain background
characteristics.text: 20171023_Day5-drug_2_H3K27ac_C6
characteristics.characteristic: title